Cantrell Drug Company announces recall
July 31, 2017
The Cantrell Drug Company is voluntarily recalling all lots of unexpired sterile drug products due to sterility issues.
The affected products include all lots distributed Feb. 16 to July 19 packaged in a syringe or IV bag. Administrating a drug product that is intended to be sterile but is not could lead to serious, potentially life-threatening infections, according to the company.
Those who have a product subject to the recall should cease using it and contact the company.
The recalled products were distributed to healthcare facilities across the country with the exception of Connecticut, Hawaii, South Carolina and Vermont. Cantrell states it has not received reports of adverse events.
Cantrell Drug Company can be contacted at 877-666-5222 from 9 a.m. to 5 p.m. CST Monday through Friday.
Adverse reactions or quality issues from product use can be reported to the FDA’s MedWatch Adverse Event Reporting program online or by mail or fax to 800-332-0178.
For more information, visit the FDA website: www.fda.gov/Safety/Recalls/ucm568494.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.